Abstract
New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Current Radiopharmaceuticals
Title: Production and Application of Copper Radiopharmaceuticals
Volume: 2 Issue: 2
Author(s): Amir Reza Jalilian, Pejman Rowshanfarzad and Mahsheed Sabet
Affiliation:
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Abstract: New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Export Options
About this article
Cite this article as:
Jalilian Reza Amir, Rowshanfarzad Pejman and Sabet Mahsheed, Production and Application of Copper Radiopharmaceuticals, Current Radiopharmaceuticals 2009; 2 (2) . https://dx.doi.org/10.2174/1874471010902020092
DOI https://dx.doi.org/10.2174/1874471010902020092 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Wet-lab Tested MicroRNA Assays for qPCR Studies with SYBR<sup>®</sup> Green and DNA Primers in Pig Tissues
MicroRNA Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Heterologous Production of Death Ligands’ and Death Receptors’ Extracellular Domains: Structural Features and Efficient Systems
Protein & Peptide Letters Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Insights Into Effects of Ellagic Acid on the Nervous System: A Mini Review
Current Pharmaceutical Design Therapeutic Targeting of G-Protein Coupled Receptor-Mediated Epidermal Growth Factor Receptor Transactivation in Human Glioma Brain Tumors
Mini-Reviews in Medicinal Chemistry Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection
Current Pharmaceutical Design Innovations and Improvements in Pharmacokinetic Models Based on Physiology
Current Drug Delivery MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies
Current Pharmaceutical Biotechnology Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Modular Protein Engineering in Emerging Cancer Therapies
Current Pharmaceutical Design Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation
Current Drug Safety Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Heavy Metals and Epigenetic Alterations in Brain Tumors
Current Genomics Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer
Current Cancer Therapy Reviews